“…3). Except that the half-maximal concentration (EC50) of NT for mRNA-induced receptors (92 nM) was 6-40 times higher than those reported for native receptors Rioux, Quirion, Regoli, Leblanc & St-Pierre, 1980;Checler, Labbe, Granier, Van Rietschoten, Kitabgi & Vincent, 1982), the pharmacological properties of mRNA-induced NT receptors were essentially the same as those of native NT receptors found in smooth muscles (Carraway & Leeman, 1975;Checler et al 1982), brains (Nemeroff, Luttinger & Prange, 1980;Baldino, Davis & Wolfson, 1985), and neuronal cells (Amar, Mazella, Checler, Kitabgi & Vincent, 1985). The C-terminal hexapeptide of NT was the minimal sequence that could fully activate NT receptors, whereas the N-terminal octapeptide was ineffective either as an agonist (Fig.…”